TORONTO, April 30, 2024 /PRNewswire/ – Black Swan Graphene Inc. (“Black Swan”) (TSXV: SWAN) (OTCQB: BSWGF) (Frankfurt: R96), proudly announces the commercialization and release…
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
TAIPEI, April 30, 2024 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576),…
The Health and Wellness Brand’s Ongoing Improvements Keep Its Nutraceutical…